Cogent Biosciences Stock Soars: A Year of Gains and a $4.5M Sell
Cogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
Key factors to consider before buying crypto, including technology, adoption potential, and risk controls to guide your choice.
18,348 articlesCogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
The social security wait time has jumped to roughly an hour as backlogs grow, triggering policy scrutiny and shifting...
Climate risk scores are moving from a niche risk tool to a gatekeeper in many loan deals. This article breaks down wh...
Retirement income from Social Security isn’t a one-size-fits-all number. This deep dive explains what the average ret...
Rumors around chip supply and product timelines can move markets quickly. This guide shows how AMD typically responds...
As remitly gears up for 2025, investors should focus on growth drivers, margin potential, and the risks that could sh...
A notable hedge fund just put $20 million into BlackLine. Is this the spark a turnaround scenario needs, or a cautiou...
When a high-profile artist steps away for health, the financial ripple is real—not just for the performer, but for sp...
Space-based connectivity is drawing attention to AST SpaceMobile. This article analyzes potential price trajectories,...
Morgan Stanley warns that tariff revenue may have peaked, casting doubt on a new 15% levy. Legal questions loom and h...
Tariffs ink new policy risk, and the market reaction is painting a clear story. This article breaks down what it mean...
The SEC approves WisdomTree's request for exemptive relief, unlocking 24/7 trading and near-instant settlement for to...